Dislipidemia at different immunosuppressive protocols.
Zezina
L
L
Department of Transplantation, Latvian Academy of Medicine, Riga.
Rosental
R
R
D001379:Azathioprine / Q000009:adverse effects; D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D016572:Cyclosporine / Q000009:adverse effects; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005500:Follow-Up Studies; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced*; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D010743:Phospholipids / Q000097:blood; D011239:Prednisolone / Q000009:adverse effects; D013997:Time Factors; D014280:Triglycerides / Q000097:blood
D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D005230:Fatty Acids, Nonesterified; D007166:Immunosuppressive Agents; D010743:Phospholipids; D014280:Triglycerides; D016572:Cyclosporine; D002784:Cholesterol; D011239:Prednisolone; D001379:Azathioprine